About
“An attorney’s understanding of the details and nuances of regulatory and compliance issues is imperative, but that knowledge is only valuable to a client if they understand them as well.”
Michael Shimada advises health care clients, including health facilities, physician groups, digital health companies, public entities, investors, and others on a wide range of regulatory matters and business transactions. Michael partners with clients throughout the business life cycle: he helps clients establish their operations, advises on business entity structure and formation and navigates around regulatory roadblocks. Michael also advances clients’ interests in their commercial contracting by drafting and negotiating agreements concerning a variety of subjects such as employment, professional services, data privacy, restrictive covenants, and intellectual property.
Michael represents clients in mergers and acquisitions, joint ventures, corporate reorganizations, and other significant transactions. He advises clients on key health care regulatory issues, including fraud and abuse laws, the corporate practice of medicine, and licensing and change of ownership (“CHOW”) requirements. Michael takes a client-centered approach, diving deep into the weeds of a problem so that he can provide clear, concise, and practical counsel to his clients.
Prior to joining Hooper, Lundy & Bookman, Michael worked at a global law firm assisting employers with domestic and cross-border employment matters. He counseled employers on employment policies and practices and assisted with the “people” aspects of mergers, acquisitions, reorganizations, and spin-offs.
News & Insights
News
- HLB Advises 101 West State Street Holdings on Acquisition of Nationwide Health Care Platform from Genesis
- 35 HLB Attorneys Receive Recognition by Best Lawyers in America 2027
- HLB Lawyers Published in Westlaw Today
- 35 HLB Attorneys Receive Recognition by Best Lawyers in America 2026
- HLB Attorneys Published in Westlaw Today
- HLB Welcomes Associate Michael Shimada
Insights
- California OHCA Updates Proposed AB 1415 Pre-Transaction Notice Regulations
- California Attorney General’s Corporate Practice of Medicine (CPOM) Settlement With Carbon Health: Takeaways for the Friendly PC Model
- California’s July 1 Health Care Minimum Wage Increases And Their Impact On Exempt Employee Salary Thresholds
- California Adopts First-Ever Hospice Licensing Regulations
- California OHCA Proposes New Regulations to Implement AB 1415’s Expanded Pre-Transaction Notice Requirements for Health Care Transactions
- California Releases “104 NP” Application: Nurse Practitioner Independent Practice and What Comes Next
- California Enacts SB 25 – A “Mini-HSR” Premerger Notification Law
- AB 692: California Bans Employers From Requiring Departing Employees to Repay Training Costs And Other Debts
- California Expands Oversight of Health Care Transactions Involving Private Equity Groups, Hedge Funds, Management Services Organizations and Certain Other Noticing Entities
- California Codifies Limitations on Private Equity Involvement in Health Care
- Oregon Imposes Major Restrictions on PC-MSO Models (SB 951)
- AB 1415: New California Bill Proposes to Expand OHCA Health Care Pre-Transaction Notice Requirements to Management Services Organizations and Private Equity Groups
- SB 351: California Proposes New Restrictions on Private Equity Management of Medical and Dental Practices
- Update on BOI Reporting Rules: Supreme Court Lifts Injunction on Corporate Transparency Act but Enforcement Remains Paused
- What Healthcare Providers Need to Know About CMS Waivers and Flexibilities in Response to The Los Angeles Fires
- FTC and DOJ Withdraw Antitrust Collaboration Guidelines: Increased Uncertainty In Healthcare Competitor Collaborations
- SB 1451: New California Law Simplifies 103 and 104 NP Certification, Updates Patient Disclosures, and Clarifies Physician Licensure For Postgraduates
- New California Proposed Law Would Require Attorney General Consent for Private Equity Healthcare Transactions (AB 3129)
- What You Need to Know About the Corporate Transparency Act
- Sweeping Executive Order Sets the Stage for Federal Oversight of AI in Healthcare
- HHS Releases Long-Awaited Proposed Rule Regarding Appropriate Disincentives for Health Care Providers that Engage in Information Blocking
- Application Window Closing for California Department of Health Care Services’ $650 Million Funding Opportunity for Primary Care Practices to Advance Health Equity and Fund Practice Transformation
- DEA Extends COVID-19 Telemedicine Flexibilities for Controlled Substance Prescribing
Recognition
-
Best Lawyers
Ones to Watch, Health Care Law, 2026-2027
Professional Affiliations
-
American Bar Association
Health Law Section